Imbria Pharmaceuticals, Inc.

CIK 1745672 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Imbria Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Dec 16, 2025D/A0001104659-25-121539
Apr 1, 2025D0001745672-25-000003
Jul 2, 2020D0001713695-20-000004
Jul 9, 2018D0001745672-18-000001